South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Global Markets Direct, August 2009, Pages: 75

“South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020” provides in-depth analysis of the South and Central American API market with revenue forecasts up to 2020. The revenue forecasts, which include historical statistics of the market, are provided for the countries – Brazil and Mexico . The factors that drive and restrain the growth of the API market in South and Central America are also analyzed in the report. In addition, the research provides the market share analysis of the leading API producers in the region. The market for each country is analyzed based on product types and customer base.

Scope

- Market revenues data from 2000 to 2008 and forecast for 12 years to 2020.
- API market in key countries – Mexico and Brazil.
- Coverage of the two major product segments of the API market in South and Central America – Synthetic and Biotech API.
- The two broad market sectors for synthetic APIs based on customer base, generic and innovative, have been included and revenue forecasts and analysis is provided for Mexico and Brazil.
- Drivers such as increasing demand for generic and biotech drugs and restraints such as the economic recession and price erosion for the South and Central American API market are also analyzed in the report.
- Information on the competitive landscape with the revenue shares of the leading companies such as Lonza, DSM, and Evonik Degussa.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the API market in South and Central America.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the API market in South and Central America.
- Capitalize by identifying the API market segments poised for strong growth.
- Identify macro and micro-economic trends shaping and driving the API market in the region.

1 Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 What is this Report About?
2.2 GMD Report Coverage

3 Executive Summary
3.1 Market Introduction and Overview
3.2 Industry Challenges
3.3 Market Drivers
3.4 Market Restraints
3.5 Total Market Revenue Forecasts
3.6 Revenue Share Analysis by Product Types
3.7 Competitive Landscape
3.8 Conclusion

4 South and Central America Active Pharmaceutical Ingredients Market
4.1 Market Overview
4.2 Product Types
4.2.1 Types Based on Synthesis Routes
4.2.2 Types based on Customer Base
4.3 Industry Structure
4.4 Industry Challenges
4.4.1 Regulatory Challenges Lead to Delay in Launch of the Drugs in the Market
4.4.2 Price Reductions Lead to Shrinking Margins for the API Producers in South and Central America
4.5 Market Drivers
4.5.1 Growth in Pharmaceutical Industry Keeps the API Market Growing in South and Central America
4.5.2 Generic Sector Augments the Growth of API Market in South and Central America
4.5.3 Biotechnology a Significant Growth Driver for the South and Central American API Market
4.6 Market Restraints
4.6.1 Slowdown in Innovative Sector Bound to Hamper the growth of the South and Central American API Market
4.6.2 Current Economic Crisis Slows the Growth of the API Market in South and Central America
4.6.3 Declining Prices Erode the Revenue Growth of the South and Central API Market
4.7 Total Revenue Forecasts
4.8 Analysis by Product Types Based on Synthesis Routes
4.8.1 Revenue Share Analysis
4.8.2 South and Central America Synthetic API Market Analysis
4.8.3 South and Central America Biotech API Market Analysis
4.8.4 Revenue Share Trend Analysis
4.9 Analysis of Synthetic API Market by Customer Base
4.9.1 Revenue Share Analysis
4.9.2 South and Central America Synthetic Innovative API Market Analysis
4.9.3 South and Central America Synthetic Generic API Market Analysis
4.9.4 Revenue Share Trend Analysis
4.10 Analysis by Countries
4.11 Competitive Landscape
4.12 Market Share Analysis

5 Mexico Active Pharmaceutical Ingredients Market
5.1 Market Introduction and Overview
5.2 Market Drivers
5.2.1 Growth in Pharmaceutical Industry Drives the Overall Growth of the API Market in Mexico
5.2.2 Generics Augment the Growth of the Mexican API Market
5.3 Market Restraints
5.3.1 Decreasing Focus on Innovative Sector Reduces the Growth of API Market in Mexico
5.3.2 Economic Recession Slows the Growth of API Market
5.4 Total Revenue Forecasts
5.5 Revenue Share Analysis by Product Types
5.6 Revenue Forecasts of Synthetic API by Customer Base
5.7 Revenue Share Analysis of Synthetic API by Customer Base

6 Brazil Active Pharmaceutical Ingredients Market
6.1 Market Introduction and Overview
6.2 Market Drivers
6.2.1 Generic Drugs Sector Boosts the Growth of the Brazilian API Market
6.2.2 Ageing Population Drives the Sales of API in Brazil
6.2.3 Increasing Focus on Biotechnology Drives the Growth of API Brazilian API Market
6.3 Market Restraints
6.3.1 Economic Recession Hampers the Growth of API Market in Brazil
6.3.2 Reducing Demand for the Innovative APIs Slows the Growth of the Brazilian API Market
6.4 Total Revenue Forecasts
6.5 Revenue Share Analysis by Product Types
6.6 Revenue Forecasts of Synthetic API by Customer Base
6.7 Revenue Share Analysis of Synthetic API by Customer Base

7 Appendix
7.1 Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Expert Panel Validation
7.2 Unit of Measure
7.3 Contact Us
7.4 About Global Markets Direct
7.5 Disclaimer

List of Tables:

Table 1: South and Central America API Market, Revenue Forecasts, 2000-2020
Table 2: South and Central America, Revenue Share Analysis by Product Types, 2008
Table 3: South and Central America Synthetic API Market, Revenue Forecasts, 2000-2020
Table 4: South and Central America Synthetic API Market, Revenue Share Analysis by Countries, 2008
Table 5: South and Central America Biotech API Market, Revenue Forecasts, 2000-2020
Table 6: South and Central America Biotech API Market, Revenue Share Analysis by Countries, 2008
Table 7: South and Central America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008
Table 8: South and Central America Synthetic Innovative API Market, Revenue Forecasts, 2000-2020
Table 9: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008
Table 10: South and Central America Synthetic Generic API Market, Revenue Forecasts, 2000-2020
Table 11: South and Central America Synthetic Generic API Market, Revenue Share Analysis by Countries, 2008
Table 12: South and Central America API Market, Revenue Share Analysis by Countries, 2008
Table 13: Mexico API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020
Table 14: Mexico API Market, Revenue Share Analysis by Product Types Based on Synthesis Routes, 2000-2020
Table 15: Mexico Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020
Table 16: Mexico Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020
Table 17: Brazil API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020
Table 18: Brazil API Market, Revenue Share Analysis by Product Types, 2000-2020
Table 19: Brazil Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020
Table 20: Brazil Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020

List of Figures:

Figure 1: South and Central America API Market, Revenue Forecasts, 2000-2020
Figure 2: South and Central America API Market, Revenue Share Analysis by Product Types, 2008
Figure 3: South and Central America API Market, Product Types
Figure 4: South and Central America API Market, Value Chain, 2008
Figure 5: South and Central America API Market, Market Drivers and Restraints, 2009-2020
Figure 6: South and Central America API Market, Population Growth by Countries, 2005-2025
Figure 7: South and Central America API Market, Revenue Forecasts, 2000-2020
Figure 8: South and Central America, Revenue Share Analysis by Product Types, 2008
Figure 9: South and Central America Synthetic API Market, Revenue Forecasts, 2000-2020
Figure 10: South and Central America Synthetic API Market, Revenue Share Analysis by Countries, 2008
Figure 11: South and Central America Synthetic API Market, Growth Rate Comparison of Countries, 2008-2020
Figure 12: South and Central America Synthetic API Market, Revenue Share Trend Analysis by Countries, 2008-2020
Figure 13: South and Central America Biotech API Market, Revenue Forecasts, 2000-2020
Figure 14: South and Central America Biotech API Market, Revenue Share Analysis by Countries, 2008
Figure 15: South and Central America Biotech API Market, Growth rate Comparison of Countries, 2008-2020
Figure 16: South and Central America Biotech API Market, Revenue Share Trend Analysis by Countries, 2000-2020
Figure 17: South and Central America API Market, Revenue Share Trend Analysis by Product Types, 2000-2020
Figure 18: South and Central America Synthetic API Market, Revenue Share Analysis by Customer Base, 2008
Figure 19: South and Central America Synthetic Innovative API Market, Revenue Forecasts, 2000-2020
Figure 20: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008
Figure 21: South and Central America Synthetic Innovative API Market, Revenue Share Analysis by Countries, 2008
Figure 22: South and Central America Synthetic Innovative API Market, Revenue Share Trend Analysis by Countries, 2008
Figure 23: South and Central America Synthetic Generic API Market, Revenue Forecasts, 2000-2020
Figure 24: South and Central America Synthetic Generic API Market, Revenue Share Analysis by Countries, 2008
Figure 25: South and Central America Synthetic Generic API Market, Revenue Share Trend Analysis by Countries
Figure 26: South and Central American Synthetic Generic API Market, Revenue Share Trend Analysis by Countries, 2000-2020
Figure 27: South and Central America Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020
Figure 28: South and Central America API Market, Revenue Share Analysis by Countries, 2008
Figure 29: South and Central America API Market, Revenue Growth Rate Comparison by Countries, 2008-2020
Figure 30: South and Central American API Market, Revenue Share Trend Analysis by Countries, 2000-2020
Figure 31: South and Central America API Market, Competitive Factors, 2009-2020
Figure 32: South and Central America API Market, Revenue Share Analysis by Companies
Figure 33: Mexico API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020
Figure 34: Mexico API Market, Revenue Share Analysis by Product Types Based on Synthesis Routes, 2000-2020
Figure 35: Mexico Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020
Figure 36: Mexico Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020
Figure 37: Brazil API Market, Revenue Forecasts by Product Types Based on Synthesis Routes, 2000-2020
Figure 38: Brazil API Market, Revenue Share Analysis by Product Types, 2000-2020
Figure 39: Brazil Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020
Figure 40: Brazil Synthetic API Market, Revenue Share Analysis by Customer Base, 2000-2020
Figure 41: Global Markets Direct Methodology

South and Central America Active Pharamceutical Ingredients Market Analysis and Forecasts to 2020

Global Markets Direct’s new report “South and Central America Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020” provides in-depth analysis of the South and Central American Active Pharmaceutical Ingredients (API) market and presents revenue forecasts up to 2020 for Mexico and Brazil. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole South and Central American market is also covered in the report.

Economic Crisis Slows the Revenue Growth of the South and Central American API Market

The current global economic crisis has negatively affected the South and Central American API market leading to a drastic reduction in its growth. The economic crisis has necessitated the need for the governments to reduce their expenditure even in the healthcare sector. Therefore, in an attempt to realize significant savings in healthcare expenditure, there is a shift away from the high-priced innovative drugs in Mexico and Brazil. This has resulted in a significant slowdown in the revenue growth of the South and Central American API market. In 2009, the South and Central American API market is set to grow at a rate of around 2%.

Brazil Set to Overtake Mexico in the South and Central American API Market by 2020

The Brazilian API market, the second largest market in South and Central America, is set to overtake Mexico in its revenue share by 2020. The Brazilian API market is characterized by an emerging biotech API product segment which is the fastest growing in the South and Central American market. Adding to this, the Brazilian pharmaceutical industry is strong and growing at a healthier rate than Mexico and other countries. This higher growth is set to enable the Brazilian API market to gain revenue share during the period 2008-2020. By 2020, Brazil is expected to hold a revenue share of around 30% and Mexico around 28%.

Biotech APIs Set to Drive the Overall Growth of the API Market in South and Central America

The biotech API market in South and Central America is geared for a higher growth which is set to drive the overall growth of the API market. The increasing demand for biological drugs is boosting the demand for the biotech API in the market place. In addition, the technological advancement in the pharmaceutical industry is paving the way for newer biotechnology drugs. This will boost the growth of the biotech API market making it grow at a rate which is significantly higher than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 7% from 2008 to 2020.

Customers who bought this item also bought

• Medical Nutrition - A Global Market Overview
• Diabetes Diagnostics - Global Strategic Business Report
• Disinfectants - Global Strategic Business Report
• Syringes (Disposable and Reusable) - Global Strategic Business Report
• Molecular Diagnostics - Global Strategic Business Report
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• Dental Supplies - Global Strategic Business Report
• Anesthesia Disposables - Global Strategic Business Report
• Clinical Diagnostics Automation - Global Business Strategic Report
• Ostomy and Incontinence Products - Global Strategic Business Report